Takeda's long-serving chief executive Christophe Weber has said he will retire next year, after 12 years at the Japanese drugmaker. Weber – who was briefly chief operating officer of Takeda ...
Takeda has announced a $100 million collaboration ... The Japanese pharma company, led by chief executive Christophe Weber, is looking to upgrade its R&D pipeline with some of the best cutting ...
Another example of the trend in a country where countless numbers of Japanese study English even after their school days are long over concerns Takeda ... appointed Christophe Weber from a ...
We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...
3382.T Seven & i Holdings Co., Ltd.
Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world ...
Takeda Pharmaceutical Company Limited engages in the research, development, manufacture, marketing, and out-licensing of pharmaceutical products in Japan and internationally. It offers ...